Published in Br J Pharmacol on March 01, 1986
Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator. J Cell Biol (1982) 11.87
(-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. FEBS Lett (1984) 1.11
Inhibition of human platelet functions by verapamil. Thromb Haemost (1981) 1.08
Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemost (1983) 1.03
Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets. Eur J Pharmacol (1985) 0.97
Inhibition of [3H]spiperone binding to 5-HT2 receptors of rat cerebral cortex by the calcium antagonists verapamil and D600. Eur J Pharmacol (1984) 0.84
Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors. Br J Pharmacol (1985) 0.84
Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem (1993) 7.16
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood (1996) 5.31
Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature (1993) 5.23
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
Calmodulin activation of plant microsomal Ca uptake. Proc Natl Acad Sci U S A (1980) 2.94
Red Light-enhanced Phytochrome Pelletability: Re-examination and Further Characterization. Plant Physiol (1976) 2.77
Turnover of phytochrome in pumpkin cotyledons. Plant Physiol (1973) 2.58
The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion. Kidney Int (2007) 2.37
ATP-dependent Ca uptake into plant membrane vesicles. Proc Natl Acad Sci U S A (1978) 2.24
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (1999) 2.17
Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res (1996) 2.10
Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun (1989) 2.02
Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene (1994) 2.01
Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol (1999) 1.90
De novo synthesis of phytochrome in pumpkin hooks. Plant Physiol (1973) 1.89
Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys Res Commun (1995) 1.87
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum (2001) 1.74
In Vivo Properties of Membrane-bound Phytochrome. Plant Physiol (1974) 1.73
Particle-bound phytochrome from maize and pumpkin. Nat New Biol (1973) 1.72
Activation of plant quinate:NAD 3-oxidoreductase by Ca and calmodulin. Proc Natl Acad Sci U S A (1983) 1.70
Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J Biol Chem (1995) 1.65
AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun (1992) 1.60
Specific binding of the calcium antagonist [3H]verapamil to membrane fractions from plants. J Biol Chem (1985) 1.54
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med (1992) 1.54
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut (1996) 1.53
Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc Natl Acad Sci U S A (1993) 1.44
Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene (1997) 1.44
Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem (1997) 1.41
Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev (1995) 1.39
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate. Br J Pharmacol (2012) 1.30
Aorto-caval fistula--an uncommon complication of infrarenal aortic aneurysms. Thorac Cardiovasc Surg (1994) 1.29
Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflugers Arch (1977) 1.27
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat (1995) 1.26
Sandostatin LAR in acromegalic patients: long-term treatment. J Clin Endocrinol Metab (1997) 1.26
Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res (1992) 1.25
Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis (2001) 1.25
Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res (1992) 1.24
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci (1991) 1.20
Cancer of the nasal cavity and paranasal sinuses and exposure to environmental tobacco smoke in pet dogs. Am J Epidemiol (1998) 1.18
Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem (1994) 1.18
Renal effects of adenosine and their inhibition by theophylline in dogs. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.17
Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci U S A (1993) 1.17
Prevalence of enteric zoonotic organisms in cats. J Am Vet Med Assoc (2000) 1.17
VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr Opin Biotechnol (1995) 1.16
Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab (1995) 1.15
Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int Suppl (1982) 1.13
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res (1997) 1.12
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res (1997) 1.10
Adenosine as a possible mediator of metabolic control of glomerular filtration rate. Int J Biochem (1980) 1.10
[Carcinogenic effect of 1,2-dimethylhydrazine in gold hamster]. Arzneimittelforschung (1969) 1.09
Expression cloning of a rat brain somatostatin receptor cDNA. Proc Natl Acad Sci U S A (1992) 1.09
Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood. Angiogenesis (2001) 1.08
Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther (1993) 1.08
Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J Nucl Med (1994) 1.08
Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res (1978) 1.07
Synthesis and selective vasodilating properties of esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydro-pyridine-3,5-di- carboxylic acid. Arzneimittelforschung (1989) 1.07
Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7 and staurosporine. Biochem Biophys Res Commun (1988) 1.06
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci (1991) 1.04
Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia. Pflugers Arch (1975) 1.03
Activation and substrate specificity of the human protein kinase C alpha and zeta isoenzymes. Eur J Biochem (1993) 1.03
Sequence of human protein kinase C alpha. Nucleic Acids Res (1990) 1.01
Intestinal absorption of the octapeptide SMS 201-995 visualized by fluorescence derivatization. Gastroenterology (1991) 1.01
Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas. Cancer Res (1994) 0.99
Inhibition of noradrenaline release by omega-conotoxin GVIA in the rat tail artery. Br J Pharmacol (1989) 0.99
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism (1996) 0.99
(2-[18F]fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl Med Biol (1994) 0.99
Purification and identification of calmodulin from Neurospora crassa. FEBS Lett (1981) 0.98
Binding properties of the plant photoreceptor phytochrome to membranes. J Supramol Struct (1974) 0.98
Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant (1999) 0.98
Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Ann Oncol (1995) 0.97
Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene (2000) 0.97
Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells. J Biol Chem (1992) 0.97
Myosin heavy chain kinase inactivated by Ca2+/calmodulin from aggregating cells of Dictyostelium discoideum. EMBO J (1983) 0.97
Potential role of luminal potassium in tubuloglomerular feedback. J Am Soc Nephrol (1997) 0.96
Calmodulin from neurospora crassa. General properties and conformational changes. J Biol Chem (1982) 0.96
Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem Biophys Res Commun (1996) 0.95
Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Dis Colon Rectum (1997) 0.95
Electrostatic and nonpolar peptide-membrane interactions. Lipid binding and functional properties of somatostatin analogues of charge z = +1 to z = +3. Biochemistry (1993) 0.95
Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol (2000) 0.95
Increased sensitivity of the renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. Am J Physiol (1995) 0.95
Effect of intratubular application of angiotensin 1-7 on nephron function. Kidney Blood Press Res (1997) 0.94
VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Dev Biol (1996) 0.92
Renal action of adenosine: effect on renin secretion in the rat. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.92
Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion (1994) 0.92
[Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents]. Arzneimittelforschung (1970) 0.92
Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis? Neurosurgery (1994) 0.92
Inhibitory effect of methylxanthines on feedback control of glomerular filtration rate in the rat kidney. Pflugers Arch (1977) 0.92
An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc Natl Acad Sci U S A (1998) 0.92
Interference of phorbolesters with endothelium-dependent vascular smooth muscle relaxation. Eur J Pharmacol (1986) 0.92
Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med (2003) 0.91
Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease. J Am Vet Med Assoc (1999) 0.91
Molecular pharmacology of somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.90
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosine. Br J Clin Pharmacol (1996) 0.90
The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration. Int J Colorectal Dis (1993) 0.90
Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics (1996) 0.89